You are here: Industry Insights > Sanofi

News List

Sanofi’s dengue vaccine secures FDA approval pharmaceutical-technology
May 05, 2019
Sanofi has received approval from the US Food and Drug Administration (FDA) for Dengvaxia, a vaccine that is designed to prevent all four dengue disease serotypes.
Zynquista approved in EU for certain patients with type I diabetes pharmatimes
April 29, 2019
Sanofi has announced that its joint SGLT1/SGLT2 inhibitor with Lexicon, Zynquista (sotagliflozin), has been approved in Europe for certain patients with type I diabetes.
Sanofi concludes option phase of rare disease alliance with Alnylam pharmaceutical-technology
April 23, 2019
Sanofi concludes option phase of rare disease alliance with Alnylam.
Sanofi to slash costs of certain insulin products in US pharmaceutical-technology
April 23, 2019
Sanofi to slash costs of certain insulin products in US
Alnylam and Sanofi close research phase of 2014's $700m RNAi rare disease partnership pharmafile
April 11, 2019
Alnylam and Sanofi have announced their intention to bring to an end the research and option phase of a $700 million partnership originally launched in 2014 to develop RNAi therapeutics for rare conditions.
Sanofi expands insulin savings programme in US, providing some patients access for $99 per month firstwordpharma
April 10, 2019
Sanofi announced Wednesday that under an expanded programme in the US……
Sanofi and Alnylam Amend Rare Disease Alliance contractpharma
April 09, 2019
Sanofi and Alnylam Amend Rare Disease Alliance
Sanofi plans sales layoffs—again—in primary care, diabetes fiercepharma
April 04, 2019
Sanofi has been hit hard by pricing pressure in diabetes, and now the drugmaker’s U.S. sales force is set for another round of job cuts.
Sanofi plans to ‘airlift’ flu vaccine into UK in no-deal event pharmatimes
March 27, 2019
In the wake of Brexit and the event of a no-deal exit from the European Union, French pharmaceutical giant Sanofi has said it could potentially airlift its flu vaccine into the UK.
FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes expressbpd
March 26, 2019
The setback comes as Sanofi works to revive declining sales from its diabetes division and faces increasing pressure from politicians and patient advocacy groups over the rising cost of its insulin products.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page